What Do Scattered Areas of Fibroglandular Density Mean?

Scattered areas of fibroglandular density is a breast composition category that appears on mammogram reports, and it means your breasts contain a mix of fatty tissue and fibroglandular tissue, with the denser tissue spread throughout in patches rather than concentrated in one area. It falls in the second of four standard density categories, placing it on the less-dense end of the spectrum. For most people who see this phrase on a report, the practical takeaway is reassuring: it is the most common classification and does not, by itself, call for any special follow-up beyond routine screening.

Where Scattered Fibroglandular Density Fits in the Four Categories

Radiologists classify breast density using a standardized system called BI-RADS, maintained by the American College of Radiology. It divides breast composition into four groups based on how much fibroglandular tissue shows up on a mammogram relative to fat. Those four groups, from least to most dense, are: almost entirely fatty (category A), scattered areas of fibroglandular density (category B), heterogeneously dense (category C), and extremely dense (category D). The system was updated between its fourth and fifth editions to improve consistency, but the four-tier framework stayed the same.

Categories A and B are considered “non-dense,” while C and D are considered “dense.” That binary split matters because many U.S. states and, since 2024, a federal FDA rule require that patients with dense breasts (C or D) receive a notification letter after their mammogram. If your report says “scattered areas of fibroglandular density,” you fall on the non-dense side of that line. You will typically not receive a dense-breast notification, and the standard recommendation is to continue with regular screening mammograms on the usual schedule.

What Fibroglandular Tissue Actually Is

Your breast is made up of several tissue types. Fat (adipose tissue) is soft and appears dark on a mammogram. Fibroglandular tissue is the combination of two things: the glandular structures that produce and transport milk, and the fibrous connective tissue (stroma) that supports them. On a mammogram, fibroglandular tissue appears white because it is denser than fat and absorbs more X-rays. Researchers have used machine learning on microscopic tissue samples to quantify these components, measuring the proportions of epithelial (glandular), stromal, and adipose tissue separately.

When a radiologist describes “scattered areas” of this tissue, they are saying the bright white patches are distributed across the breast rather than forming a uniform sheet. In between those patches, there is enough fatty tissue that the overall image has good contrast. This is an important practical point: cancers, which also appear white on mammograms, are easier to spot when there is surrounding dark fat for contrast. That is one reason the scattered category is considered relatively favorable for screening accuracy.

Cancer Risk Compared With Other Density Groups

Breast density is an independent risk factor for breast cancer, meaning denser breasts carry somewhat higher risk regardless of other factors. But the scattered fibroglandular category sits in the middle of the risk spectrum, and it is often used as the reference group in research studies because it is so common.

A large study of women aged 65 and older found that those with heterogeneously or extremely dense breasts had roughly 23 to 39 percent higher risk of breast cancer compared with women who had scattered fibroglandular density. Meanwhile, women with almost entirely fatty breasts had about 27 to 34 percent lower risk than the scattered group.

In plain terms, if you picture breast cancer risk on a staircase with four steps, scattered fibroglandular density sits on the second step from the bottom. It carries more risk than the fattiest breasts but meaningfully less risk than heterogeneously or extremely dense breasts. That moderate position is worth understanding, because many people see “density” on their report and assume the worst. Having some fibroglandular tissue is completely normal; the question is how much and how it compares with the denser categories.

Why Some Breasts Are Denser Than Others

Genetics plays the largest role. A twin study estimated that about 60 to 67 percent of the variation in mammographic density between individuals is attributable to inherited genetic factors.

Researchers have identified specific gene regions linked to dense and non-dense breast volume, including variants near genes involved in estrogen receptor signaling.

Hormones are the other major driver. Progesterone promotes the growth of both glandular and stromal tissue in the breast, and studies suggest it has a stronger relationship with mammographic density than estrogen does.

⁴ In postmenopausal women, progesterone’s influence on breast tissue growth has been linked to increased cancer risk as well.

⁵

Body composition matters too. Higher body mass index and higher body fat percentage are both associated with lower breast density in both premenopausal and postmenopausal women.

⁶ This happens because gaining body fat increases the amount of fatty tissue in the breast, which dilutes the proportion of fibroglandular tissue. It is an important nuance: a woman with a higher BMI might have just as much fibroglandular tissue as a thinner woman, but her mammogram may show a lower density category because there is more fat surrounding it. Higher body fat reduces the percentage density reading, but the absolute amount of dense tissue can stay the same or even increase.

⁷

How Density Changes Over a Lifetime

Breast density is not fixed. It tends to be highest in younger women and declines with age, particularly around menopause. This decline tracks the drop in endogenous estrogen levels and a biological process called lobular involution, in which the milk-producing structures in the breast gradually shrink and get replaced by fat.

⁸

A study tracking women across the menopausal transition found that dense breast volume dropped by an average of about 2.2 cubic centimeters per year. Women who started with the highest density before menopause experienced the steepest declines, losing roughly 3.5 cubic centimeters per year compared with about 1 cubic centimeter per year for those who started with lower density.

⁹

What this means in practice is that a woman classified as heterogeneously dense in her 40s might shift to scattered fibroglandular density by her 50s or 60s. And someone with scattered density in her 40s might eventually move into the almost entirely fatty category. These shifts are gradual and vary by person, which is why your density classification can change from one mammogram to the next even without any lifestyle changes.

Medications That Can Shift Your Density Category

Hormone replacement therapy (HRT) is one of the most common factors that can push density in the opposite direction from the natural age-related decline. Consistent evidence shows that HRT use is associated with increased mammographic density, with the strongest effect seen in current users and those taking combined estrogen-progestogen formulations.

¹⁰ If you are on HRT and your density category has stayed the same or increased when you expected it to decrease with age, the medication is a likely explanation.

On the other side, tamoxifen, a drug used both for breast cancer treatment and risk reduction, can lower mammographic density. A randomized trial found that even low doses of tamoxifen produced density reductions similar to the standard 20 mg dose, with a median decrease of about 10 percent, though this effect was confined to premenopausal women.

¹¹ Laboratory work has shown that tamoxifen appears to reduce density by decreasing the stromal component and increasing the fatty component of breast tissue.

¹²

What Scattered Density Means for Screening Accuracy

One of the biggest practical concerns around breast density is the masking effect: dense tissue and cancers both appear white on a mammogram, so a tumor hiding in a patch of fibroglandular tissue can be harder to spot. For women with scattered fibroglandular density, this effect is relatively mild compared with the denser categories. The contrast between the scattered white patches and the surrounding darker fatty tissue gives radiologists reasonable visibility.

A large population-based study comparing standard digital mammography with 3D mammography (breast tomosynthesis) found that tomosynthesis improved the rate of catching true cancers by 12 to 24 percent across density groups, with the improvement reaching statistical significance specifically for women in the scattered (B) and heterogeneously dense (C) categories. At the same time, tomosynthesis reduced false-positive rates across almost all groups.

¹³ For someone with scattered density, this means standard mammography works reasonably well, and tomosynthesis can squeeze out additional accuracy if available.

Callback rates provide another window into how density affects the screening experience. Women with scattered fibroglandular density who were under 50 and had one to four years since a prior mammogram had a recall rate of about 9.7 per 100 screens, compared with 11.7 per 100 for women with dense breasts in the same age and screening-interval bracket.

¹⁴ Being called back does not mean cancer has been found; most callbacks lead to additional imaging that turns out to be normal. But higher callback rates mean more anxiety, more appointments, and sometimes unnecessary biopsies. The scattered density category is associated with a moderately lower callback rate than the dense categories, which is worth knowing if you are bracing for a follow-up call.

Supplemental Screening and Ultrasound

Because scattered fibroglandular density falls into the “non-dense” classification, supplemental screening beyond mammography is generally not recommended for this group. Supplemental screening tools like breast ultrasound and breast MRI are primarily discussed in the context of women with heterogeneously or extremely dense breasts, where the masking effect is stronger.

An early study of screening ultrasound in women with dense breasts found additional cancers at a rate of about 0.46 percent, with a significantly higher detection rate in women who were already at elevated risk due to other factors.

¹⁵ The takeaway for people with scattered density is that supplemental ultrasound is not a standard recommendation for your category unless you have additional risk factors like a strong family history or a known genetic predisposition. If you are unsure, the conversation to have with your doctor is about your overall risk profile, not just your density category in isolation.

Artificial Intelligence and the Future of Reading Dense Mammograms

AI software is increasingly being tested as a tool to help radiologists catch cancers that dense tissue might hide. One study found that AI detected about 26 percent of cancers in dense-breasted women that had initially been found only on supplemental ultrasound, with nearly two-thirds of those cancers having been obscured by overlapping dense tissue on the original mammogram.

¹⁶

AI performance does vary by density category, though. A deep learning study evaluating detection of masses and distortions across all four BI-RADS density groups found sensitivity of 94 percent for the fattiest breasts, dropping to 92 percent for scattered density, 89 percent for heterogeneously dense, and 72 percent for the extremely dense group.

¹⁷ For scattered density, AI performs close to its best, which aligns with what we already know: the mix of fat and fibroglandular tissue in this category provides enough contrast for both human radiologists and algorithms to work with effectively.

The Subjectivity Problem in Density Assessment

One underappreciated issue is that your density category is not measured by a machine. A radiologist looks at your mammogram and assigns it to one of the four groups based on visual assessment. Studies comparing how well radiologists agree with themselves over time and with each other show that agreement is good but imperfect. One comparison found that intra-reader agreement was high for both experienced breast radiologists and less experienced readers, but agreement between readers was only “substantial” rather than “almost perfect.”

¹⁸

This means two radiologists could look at the same mammogram and one might call it scattered fibroglandular while the other calls it heterogeneously dense. That one-category difference can have real consequences, since it can determine whether you receive a dense-breast notification and whether supplemental screening is recommended. If your density classification shifts between mammograms without a clear reason like weight change or menopause, different radiologists’ interpretation habits are a plausible explanation. Automated volumetric density tools are being developed to reduce this variability, but visual assessment remains the standard in most settings.

How Density Notifications Affect People Emotionally

Since many U.S. states and now federal rules require that mammography reports include density information, researchers have studied how people react to learning their breast density classification. The results are somewhat mixed and depend on how the information is delivered.

A study of South Australian women found no significant difference in anxiety scores between women told they had dense breasts and those told they had non-dense breasts. Most reactions to the notification were positive or neutral, with only about 17 percent being negative.

¹⁹ Similarly, a randomized trial among Latina women at a health center found no significant difference in anxiety, cancer worry, or perceived risk between groups who received different density notification formats.

²⁰

However, a larger randomized trial in Australia’s BreastScreen program told a different story. Women notified of dense breasts reported feeling significantly more anxious and confused compared with a control group. They were also about twice as likely to say they intended to speak to their general practitioner about their results and to rely on their GP for supplemental screening advice.

²¹ The confusion finding is worth highlighting: breast density is a concept most people have never encountered before their first mammogram, and a form letter explaining it in clinical language can leave more questions than answers. If you have scattered fibroglandular density, the notification issue is largely moot since you are in the non-dense group. But if a future mammogram moves you into the heterogeneously dense category, knowing that the notification itself is not a diagnosis and that some anxiety is a documented normal reaction can help you process it calmly.

When the Category Boundary Matters Most

The border between scattered fibroglandular density (B) and heterogeneously dense (C) is the most consequential line in the BI-RADS density system, because it is the dividing line between “non-dense” and “dense” for notification and screening purposes. If your density sits right near that boundary, a small difference in interpretation can flip your classification. Body fat parameters can nudge density readings around this line: gaining weight tends to push density measurements down, while losing weight can push them up, because the proportion of fat in the breast changes even if the absolute amount of fibroglandular tissue stays roughly the same.

⁶

If you have been told you have scattered fibroglandular density but are close to the borderline, the most productive step is to have a conversation with your doctor about your complete risk picture. Density is one input among several. Family history, genetic factors, reproductive history, and whether you use hormone therapy all feed into your overall breast cancer risk. Some risk calculators used in clinical practice now incorporate density along with these other factors to give a more personalized estimate. Density alone, especially the scattered category, is not a reason to panic or to demand additional testing. It is one piece of information in a broader assessment.